Noopept (Omberacetam) – Spray, 100mg (1mg/spray)
$9.99
Noopept (Omberacetam) – Spray, 100mg (1mg/spray) is a high-purity laboratory-grade research dipeptide compound supplied as a ready-to-use aqueous solution containing 100mg Noopept (10mg/mL ± 10%) with 1mg BKC (benzyl chloride potassium, 0.1mg/mL ± 10%) stabilizer per vial for solution stability, functioning as a synthetic dipeptide derived from the racetam family (N-phenylacetyl-L-prolylglycine ethyl ester, GVS-111, DVD-111, SGS-111) with cognitive-enhancing, neuroprotective, high affinity for AMPA and NMDA receptors (involved in synaptic signaling and enzymatic regulation), NGF and BDNF protein stimulator, and GABA-modulating properties that interacts with glutamatergic and cholinergic pathways, exhibits neuroprotective effects in treating brain injuries and stroke, reduces anxiety and stress levels providing calming effect, enhances memory, learning, and focus, provides significant neuroprotection beneficial in neurodegenerative diseases like Alzheimer’s, supplied in bottle with graduated spray mechanism for convenient measurement, available for fast, compliant shipping to all U.S. states and European countries.
-
≥98% purity verified by HPLC with batch/lot coded certificates of analysis for absolute transparency
-
Formulation contains Noopept peptide in solution with BKC stabilizer for solution stability
-
100mg total amount (10mg/mL ± 10%) with 1mg BKC (0.1mg/mL ± 10%) stabilizer per vial
-
1mg per spray with graduated spray mechanism for convenient measurement; boric acid solution for stability
Noopept (Omberacetam) – Spray, 100mg (1mg/spray)
This premium laboratory-grade research dipeptide compound is supplied as a ready-to-use aqueous solution engineered for modern scientific investigations requiring precise racetam-derived dipeptide pharmacology and cognitive/neuroprotection research. Noopept (Omberacetam, GVS-111, DVD-111, SGS-111, N-phenylacetyl-L-prolylglycine ethyl ester) is a synthetic dipeptide compound derived from the racetam family, structurally related to piracetam analogs, with cognitive-enhancing, neuroprotective, high affinity for AMPA and NMDA receptors (involved in synaptic signaling and enzymatic regulation), NGF and BDNF protein stimulator, and GABA-modulating properties that interacts with glutamatergic and cholinergic pathways, exhibits neuroprotective effects in treating brain injuries and stroke, reduces anxiety and stress levels providing calming effect that can enhance overall mental performance, enhances memory, learning, and focus making it popular among students and professionals seeking mental clarity, provides significant neuroprotection beneficial in conditions like Alzheimer’s and other neurodegenerative diseases, shows both stimulant and anti-anxiety properties, is orally available, frequently dosed at 10–30 mg per day in humans although no solid evidence indicating optimal dose with few human trials carried out, animal studies have used doses ranging from 0.1 mg/kg bodyweight to 10 mg/kg bodyweight, making it a valuable tool for in vitro/in vivo modeling of cognitive enhancement, neuroprotection, neurodegenerative diseases, Alzheimer’s, brain injuries, stroke, anxiety reduction, stress reduction, glutamatergic/cholinergic pathway modulation, AMPA/NMDA receptor function, NGF/BDNF stimulation, and GABA modulation research.
All domestic orders ship directly from primary United States production facilities, ensuring rapid delivery to all 50 U.S. states. International orders to the UK and continental Europe are fulfilled through our dedicated United Kingdom shipping hub, enabling seamless, efficient customs clearance across European borders without delay.
-
Batch-coded containers with publicly accessible third-party lab reports verifying specification consistency for absolute transparency
-
Formulation contains Noopept in solution with BKC stabilizer to guarantee solution stability and peptide integrity
-
Packaging engineering utilizes spray bottle with graduated spray mechanism to maintain solution stability during transit and room temperature storage below 25°C
-
1mg per spray with less than 10% variance in concentration guarantees consistency and measurement accuracy
Technical Specifications & Chemical Profile
| Chemical Property | Specification Data |
|---|---|
| Product Name | Noopept (Omberacetam) – Spray, 100mg (1mg/spray) |
| Common Synonyms | Omberacetam, GVS-111, DVD-111, SGS-111, Benzylcarbonyl-Pro-Gly-OEt, N-Phenylacetyl-L-prolylglycine ethyl ester, N-[1-(Phenylacetyl)-L-prolyl]glycine ethyl ester, Ethyl N-[1-(Phenylacetyl)-L-prolyl]glycinate, Noopept (Russian: Ноопепт), racetam-derived dipeptide, synthetic dipeptide, nootropic dipeptide, neuroprotective dipeptide, AMPA receptor modulator, NGF stimulator, BDNF stimulator |
| CAS Number | 157115-85-0 |
| Molecular Formula | C₁₇H₂₂N₂O₄ |
| Molar Mass | 318.37–318.4 g/mol |
| Synthesis First Reported | 1996 |
| IUPAC Name | ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate [(S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate] |
| Primary Target Mechanism | Synthetic dipeptide derived from racetam family; structurally related to piracetam analogs; cognitive enhancer enhancing memory, learning, and focus; neuroprotective agent providing significant neuroprotection beneficial in Alzheimer’s and neurodegenerative diseases; high affinity for AMPA and NMDA receptors (involved in synaptic signaling and enzymatic regulation); AMPA receptor modulator potentially for treatment of cognitive deficits; NGF and BDNF protein stimulator; interacts with glutamatergic pathways; interacts with cholinergic pathways; prodrug of cyclic glycine-proline; GABA-modulating properties; exhibits neuroprotective effects in treating brain injuries and stroke; reduces anxiety and stress levels providing calming effect enhancing mental performance; both stimulant and anti-anxiety properties; orally available; frequently dosed at 10–30 mg per day in humans; no solid evidence indicating optimal dose; few human trials carried out; animal studies using doses 0.1 mg/kg to 10 mg/kg bodyweight; promises as nootropic; short half-life; evidence in several mouse models suggests neuroprotective effect |
| Physical Form | Solution in boric acid solution; liquid spray |
| Specification | Noopept 100mg (10mg/mL ± 10%); BKC 1mg (0.1mg/mL ± 10%) per vial |
| Total Amount | 100mg Noopept + 1mg BKC per vial |
| Per Spray | 1mg Noopept per spray |
| Purity | ≥98% (HPLC) |
| Solubility | Soluble in DMSO (up to 25 mg/ml); soluble in aqueous solution; boric acid solution for stability |
| Storage | Store at temperatures below 25°C, avoid exposure to sun; store container tightly closed in dry, cool place; solutions can be stored at -20°C for up to 1 month; shelf life up to 12 months |
Research Applications & Storage Protocols
Racetam-Derived Dipeptide with AMPA/NMDA Modulation and NGF/BDNF Stimulation Profile
Noopept functions as a synthetic dipeptide compound derived from the racetam family, structurally related to piracetam analogs, with high affinity for AMPA and NMDA receptors involved in synaptic signaling and enzymatic regulation, NGF and BDNF protein stimulator, and is a prodrug of cyclic glycine-proline serving as AMPA receptor modulator potentially for treatment of cognitive deficits. The compound demonstrates cognitive enhancer enhancing memory, learning, and focus making it popular among students and professionals seeking mental clarity, exhibits neuroprotective effects beneficial in conditions like Alzheimer’s and other neurodegenerative diseases, provides significant neuroprotection, interacts with glutamatergic pathways and cholinergic pathways, has GABA-modulating properties, reduces anxiety and stress levels providing calming effect that can enhance overall mental performance, shows both stimulant and anti-anxiety properties, is orally available, frequently dosed at 10–30 mg per day in humans (no solid evidence indicating optimal dose, few human trials carried out), animal studies use doses ranging from 0.1 mg/kg bodyweight to 10 mg/kg bodyweight, has very short half-life but evidence in several mouse models suggests neuroprotective effect, making it valuable for investigators studying cognitive enhancement, neuroprotection, neurodegenerative diseases, Alzheimer’s, brain injuries, stroke, anxiety reduction, stress reduction, glutamatergic/cholinergic pathway modulation, AMPA/NMDA receptor function, NGF/BDNF stimulation, and GABA modulation research.
Handling & Storage Guidelines
-
Long-Term Storage: Store at room temperature below 25°C, tightly sealed, away from heat, light and moisture; avoid exposure to sun; spray bottle provides UV protection; solution requires storage below 25°C to remain stable; solutions can be stored at -20°C for up to 1 month; shelf life up to 12 months
-
Solubility: Supplied pre-dissolved in boric acid solution at 10mg/mL; soluble in DMSO up to 25 mg/ml; soluble in aqueous solution; liquid spray appearance
-
Spray Measurement: Graduated spray mechanism included for convenient measurement; 1mg per spray; less than 10% variance guarantees consistency
Legal Status & Regulatory Information
-
Australia: S4 (Prescription only)
-
United States: Unapproved “New Drug” (21 U.S. Code § 321(p)(1)); Use in dietary supplements, food, or medicine is unlawful; otherwise uncontrolled
-
Hungary: As of 25 August 2020, added to controlled psychoactive substances list, prohibiting production, sale, import, storage and use
-
Russia: Drug of medicine, available without prescription
-
United Kingdom: Not illegal to produce, supply, or import under Psychoactive Substance Act (came into effect May 26, 2016) because it neither works as CNS depressant nor CNS stimulant; however, sale and supply for human consumption are prohibited
Global Logistics & Order Fulfillment
We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.
Laboratory Use Only Disclaimer
This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. Noopept (Omberacetam) is not approved by the FDA and is sold strictly for scientific research use only. It is not intended for human or veterinary use. Always consult with a healthcare professional before starting any new supplement or research product. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.
| pa_feature |
Discountinued |
|---|---|
| pa_form |
Sprays |
| pa_types |
Racetams |
You must be logged in to post a review.


Reviews
There are no reviews yet.